Related references
Note: Only part of the references are listed.Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
Chaoyuan Kuang et al.
CLINICAL EPIGENETICS (2022)
Aspirin in the Prevention of Colorectal Neoplasia
David A. Drew et al.
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021 (2021)
MCPIP1 Enhances TNF-α-Mediated Apoptosis through Downregulation of the NF-κB/cFLIP Axis
Fat-Moon Suk et al.
BIOLOGY-BASEL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Regulation of Nuclear Factor-KappaB (NF-kB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Sepideh Mirzaei et al.
CANCER LETTERS (2021)
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
Chunhong Hu et al.
CLINICAL EPIGENETICS (2021)
MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression
Zhaozhou Ren et al.
CANCER BIOLOGY & THERAPY (2020)
Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer
Atena Soleimani et al.
GENE (2020)
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
Kirsty Taylor et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors
Judyta Gorka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cancer Epigenetics, Tumor Immunity, and Immunotherapy
Jian Cao et al.
TRENDS IN CANCER (2020)
MCPIP1 alleviated lipopolysaccharide-induced liver injury by regulating SIRT1 via modulation of microRNA-9
Shichao Han et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Substrate specificity of human MCPIP1 endoribonuclease
Mateusz Wilamowski et al.
SCIENTIFIC REPORTS (2018)
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study
Nilofer S. Azad et al.
ONCOTARGET (2017)
A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis
Lele Song et al.
CANCER BIOMARKERS (2017)
MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression
Paulina Marona et al.
CANCER RESEARCH (2017)
MCPIP1 contributes to clear cell renal cell carcinomas development
Janusz Ligeza et al.
ANGIOGENESIS (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression
Wenbao Lu et al.
CANCER RESEARCH (2016)
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
Michael J. Overman et al.
ONCOTARGET (2016)
Expression and Clinical Significance of Tumor Necrosis Factor Receptor Associated Factor 6 in Patients With Colon Cancer
Tao Zhang et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2016)
MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation
Abhishek V. Garg et al.
IMMUNITY (2015)
Monocyte Chemotactic Protein-induced Protein 1 and 4 Form a Complex but Act Independently in Regulation of Interleukin-6 mRNA Degradation
Shengping Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
TRAF6 is upregulated in colon cancer and promotes proliferation of colon cancer cells
Heng Sun et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis
Arpita Roy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
I. Garrido-Laguna et al.
INVESTIGATIONAL NEW DRUGS (2013)
KRAS Mutation and NF-κB Activation Indicates Tolerance of Chemotherapy and Poor Prognosis in Colorectal Cancer
Gen Lin et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Regulation of NF-κB by deubiquitinases
Edward W. Harhaj et al.
IMMUNOLOGICAL REVIEWS (2012)
Structural study of MCPIP1 N-terminal conserved domain reveals a PIN-like RNase
Jiwei Xu et al.
NUCLEIC ACIDS RESEARCH (2012)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
MCPIP1 Ribonuclease Antagonizes Dicer and Terminates MicroRNA Biogenesis through Precursor MicroRNA Degradation
Hiroshi I. Suzuki et al.
MOLECULAR CELL (2011)
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
Jian Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The Role of Ubiquitin in NF-kappa B Regulatory Pathways
Brian Skaug et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth
Kei Sakamoto et al.
CLINICAL CANCER RESEARCH (2009)
Lysine 63 Polyubiquitination in Immunotherapy and in Cancer-promoting Inflammation
Ivan Martinez-Forero et al.
CLINICAL CANCER RESEARCH (2009)
Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1β mRNA
Danuta Mizgalska et al.
FEBS JOURNAL (2009)
Nonproteolytic Functions of Ubiquitin in Cell Signaling
Zhijian J. Chen et al.
MOLECULAR CELL (2009)
Inflammation and cancer: Role of nuclear factor-kappaB activation
Shin Maeda et al.
CANCER SCIENCE (2008)
Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells
Yun Ling et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Proteasome-independent functions of ubiquitin in endocytosis and signaling
Debdyuti Mukhopadhyay et al.
SCIENCE (2007)
Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction
Limei Zhou et al.
CIRCULATION RESEARCH (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies
F Lyko et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
